Howard Horn's Insider Trades & SAST Disclosures
Howard Horn's most recent trade in Ultragenyx Pharmaceutical Inc. was a trade of 1,785 Common Stock done at an average price of $40.4 . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Howard Horn.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical ... | Howard Horn | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.40 per share. | 06 Mar 2025 | 1,785 | 106,169 (0%) | 0% | 40.4 | 72,114 | Common Stock |
| Ultragenyx Pharmaceutical ... | Howard Horn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 28,160 | 28,160 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Howard Horn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 15,653 | 107,954 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Howard Horn | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 52.76 per share. | 10 Oct 2024 | 7,465 | 92,301 (0%) | 0% | 52.8 | 393,853 | Common Stock |
| Ultragenyx Pharmaceutical ... | Howard Horn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 34,200 | 34,200 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Howard Horn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 19,400 | 99,766 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Howard Horn | CFO | Sale of securities on an exchange or to another person at price $ 25.97 per share. | 23 Feb 2023 | 2,248 | 230,712 (0%) | 0% | 26.0 | 58,387 | Common Stock |
| Vir Biotechnology Inc | Howard Horn | CFO | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 17 Feb 2023 | 2,424 | 232,960 (0%) | 0% | 25.3 | 61,298 | Common Stock |
| Vir Biotechnology Inc | Howard Horn | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Howard Horn | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 35,000 | 235,384 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Howard Horn | CFO | Sale of securities on an exchange or to another person at price $ 31.93 per share. | 17 Feb 2022 | 2,393 | 200,384 (0%) | 0% | 31.9 | 76,411 | Common Stock |
| Vir Biotechnology Inc | Howard Horn | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Howard Horn | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 25,000 | 202,777 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Howard Horn | CFO | Sale of securities on an exchange or to another person at price $ 50.06 per share. | 13 Jul 2020 | 30,000 | 177,777 (0%) | 0% | 50.1 | 1,501,731 | Common Stock |
| Vir Biotechnology Inc | Howard Horn | CFO | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 01 Jul 2020 | 10,000 | 207,777 (0%) | 0% | 40 | 400,000 | Common Stock |
| Vir Biotechnology Inc | Howard Horn | CFO | Sale of securities on an exchange or to another person at price $ 37.72 per share. | 01 Jul 2020 | 9,100 | 218,677 (0%) | 0% | 37.7 | 343,275 | Common Stock |
| Vir Biotechnology Inc | Howard Horn | CFO | Sale of securities on an exchange or to another person at price $ 38.78 per share. | 01 Jul 2020 | 500 | 218,177 (0%) | 0% | 38.8 | 19,392 | Common Stock |
| Vir Biotechnology Inc | Howard Horn | CFO | Sale of securities on an exchange or to another person at price $ 39.33 per share. | 01 Jul 2020 | 400 | 217,777 (0%) | 0% | 39.3 | 15,732 | Common Stock |
| Vir Biotechnology Inc | Howard Horn | CFO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 25 Jun 2020 | 30,000 | 227,777 (0%) | 0% | 50 | 1,500,000 | Common Stock |
| Vir Biotechnology Inc | Howard Horn | CFO | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 19 Jun 2020 | 10,000 | 257,777 (0%) | 0% | 40 | 400,000 | Common Stock |
| Vir Biotechnology Inc | Howard Horn | CFO | Sale of securities on an exchange or to another person at price $ 35.38 per share. | 01 Jun 2020 | 6,714 | 267,777 (0%) | 0% | 35.4 | 237,573 | Common Stock |
| Vir Biotechnology Inc | Howard Horn | CFO | Sale of securities on an exchange or to another person at price $ 34.53 per share. | 01 Jun 2020 | 3,286 | 274,491 (0%) | 0% | 34.5 | 113,465 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges